News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
269 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (119)
3 (12)
4 (242)
5 (269)
6 (241)
7 (243)
8 (78)
9 (2)
10 (3)
11 (232)
12 (312)
13 (213)
14 (243)
15 (110)
16 (8)
17 (9)
18 (85)
19 (267)
20 (246)
21 (243)
22 (113)
23 (7)
24 (12)
25 (220)
26 (276)
27 (239)
28 (312)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
New Healthcare Clients Drive SCI Growth
SCI Launches New Healthcare Facility in Mississauga
February 5, 2019
·
2 min read
Drug Development
Mallinckrodt Provides Update on Phase 4 Data H.P. Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Patients with Rheumatoid Arthritis (RA)
Open-label phase of study completed; primary end point results consistent¹ with prior reports (n=116) that showed 61% of patients with persistently active RA reported in the open-label period achieved low disease activity at 12 weeks
February 5, 2019
·
12 min read
Business
Holy Redeemer and Prepared Health Partner to Connect Health System, Align Post-Acute Network
After successful partnership with its Home Care unit, the Pennsylvania-based health system adds Hospital and Life Care Centers to Prepared Health’s digital enTouch network
February 5, 2019
·
3 min read
Deals
Resonetics Announces Acquisition Of Caribou Technologies
Adds innovative grinding, forming, coiling and machining capabilities with Minneapolis hub
February 5, 2019
·
3 min read
Pharm Country
CytoSorbents to Present at the 21st Annual BIO CEO & Investor Conference
CytoSorbents Corporation announced that its Chief Executive Officer, Dr.
February 5, 2019
·
6 min read
Pharm Country
Newly Launched ANSYS Cloud Accelerates Engineering Productivity and Business Agility
ANSYS Cloud enables instant access to cloud HPC from within ANSYS flagship products
February 5, 2019
·
4 min read
Biotech Bay
CLIOSS Implements Veeva Vault Clinical Applications to Streamline Trial Management
Italian CRO standardizes on Vault eTMF and Vault CTMS to improve trial efficiency and enhance collaboration with sponsors
February 5, 2019
·
5 min read
BioCapital
Gemedy and ACET Awarded $28 Billion, 9-Year Defense Contract
Gemedy to provide U.S. Department of Defense’s Defense Technical Information Center with artificial intelligence research and development services.
February 5, 2019
·
2 min read
Business
HSBlox’s Blockchain Technology Automates & Scales Bundled Payments
CuraBlox utilizes distributed ledger technology and smart contracts to ease administrative burden and accelerate value-based payment models
February 5, 2019
·
2 min read
Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect’s ApoGraft™ for Bone Marrow Transplantations
The Collaboration will be led by Renowned Cell and Gene Therapy Experts Dr. John DiPersio and Dr. Mark Schroeder with Advisory support to Cellect by Prof. Negrin of Stanford and Dr. Cutler of Harvard Medical School
February 5, 2019
·
8 min read
Previous
2 of 27
Next